01Translate the assay name into an observed feature

The Assay Guidance Manual describes caspase-3/7 activity and exposure of phosphatidylserine at the cell surface as commonly measured apoptosis-associated markers. Annexin V binding is used to detect the latter; it measures a different feature from caspase substrate cleavage.Assay Guidance Manual — Apoptosis Marker Assays for HTS (opens in a new tab)

An activity assay and a binding assay therefore need separate descriptions. For a paper containing both, record their units and whether they were measured in the same samples or in parallel experiments. Similar-looking graphs do not establish that the underlying observations are identical.

The Nomenclature Committee on Cell Death recommends reporting the actual cellular or biochemical parameter rather than an unexplained percentage of apoptosis. Its abstract also cautions about defining death types through morphology without clear biochemical mechanisms.NCCD — Classification of cell death: recommendations, 2009 (opens in a new tab)

This is a practical writing rule: preserve “annexin-positive cells” or “caspase-associated signal” until the paper provides the additional evidence needed for a broader interpretation.

02Read the sequence of observations

The manual explains that apoptosis markers are dynamic and that endpoint timing can affect their detection. It discusses combining annexin binding with a membrane-integrity readout to distinguish observations made before and after membrane compromise.Assay Guidance Manual — Apoptosis Marker Assays for HTS (opens in a new tab)

The table does not prescribe a universal sequence or timing. It shows why a late snapshot can leave questions that earlier observations would address. Different experiments must retain their own reported timeline.

For example, a fictional final caspase signal lower than an earlier signal cannot by itself establish recovery. The missing question is what happened to the cells over the interval, not simply which bar is smaller.

03Check what the reported percentage counts

Suppose a fictional analysis identifies 30 marker-positive cells among 100 analysed cells. Its positive fraction is 30%. If 40 other cells from the original population were not analysed, the result does not tell you their marker status.

That distinction matters when a figure uses a selected field, a gated population or only cells retained after preparation. Ask how the analysed population was defined and whether exclusions were comparable between conditions.

Do not silently recalculate the missing cells as positive or negative. A transparent evidence note records the observed fraction and the incomplete coverage separately. It may be possible to resolve the issue from supplementary methods or absolute counts.

04Separate marker suppression from protection

A fictional peptide condition reduces an apoptosis-associated signal. At that stage the supported claim concerns the signal under the tested conditions. To call the effect protective, the paper needs evidence that the relevant cellular outcome improved, rather than only that this marker changed.

Inspect whether the detection chemistry itself was assessed and whether another outcome supports the interpretation. A complementary measurement is valuable because it can address an uncertainty left by the first, not because two assays automatically prove a mechanism.

If a mechanism is proposed, distinguish the observed marker pattern from experiments testing causal involvement. Use the authors’ uncertainty and the actual intervention evidence when describing that step.

Your final note should identify the cell model, markers, observation times and supported conclusion. It should also retain any unresolved population or timing issue that materially changes the interpretation.